Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can fiber and probiotics boost immunity in colorectal cancer patients?

NCT ID NCT07194954

Disease control Sponsor: The First Hospital of Hebei Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether taking a daily mix of dietary fiber and probiotics for 12 weeks could improve gut bacteria, immune function, and nutrition in 80 malnourished patients with advanced colorectal cancer. Participants received either the supplement or standard nutritional advice. The goal was to see if this simple addition could help their bodies fight cancer better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Combined dietary fiber powder (inulin, pectin, β-glucan) and multi-strain probiotic capsule (Lactobacillus acidophilus, Bifidobacterium lactis, Streptococcus thermophilus)
What this could lead to
If it works, this could point toward a simple dietary supplement to boost immune function and nutritional status in advanced colorectal cancer patients.
What could go wrong
This is a small, single-center trial with only 80 participants, so results may not apply to all patients. The supplements may cause digestive discomfort or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

May 2022

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pathologically confirmed diagnosis of stage II-IV colorectal cancer post-resection. * Receiving active adjuvant chemotherapy. * Documented moderate-to-severe malnutrition (PG-SGA score ≥ 4). * Ability to tolerate oral intake. * Voluntarily signed the informed consent form. Exclusion Criteria: * Presence of complete bowel obstruction. * Severe, uncontrolled organ dysfunction (cardiac, hepatic, renal). * Known allergy to any component of the nutritional supplements. * Concurrent participation in another interventional trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer (msi-H) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm Malnutrition nutritional deficiency disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal cancer (msi-H) Malnutrition (calorie)

Contacts and locations

Locations

  • First Hospital of Hebei Medical University

    Shijiazhuang, Hebei, 050000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.